TTP

Cell therapies have shown the ability to cure the incurable and yet we cannot get them to patients because of an inability to scale manufacturing. The Cellular Origins team is transforming patient access to cell therapies by addressing the challenges associated with scalable, cost-effective and efficient manufacture.

We’re developing a robotic automation solution that uniquely combines aseptic fluid-handling technologies with advanced robotics. We’re working with the world’s leading cell therapy companies and alongside the most innovative tools and technology developers to create a solution that enables a monumental step change in manufacturing.

We will be growing rapidly in 2025, so if you’re excited about our mission, we’d love to hear from you.